A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.
News included in the supplement:
- Ultrathin stent loses advantage at 3 years
- Adjunctive devices for TAVR boost outcomes
- MI alert device shows predictive value
- Readmissions high post STEMI with cardiogenic shock
- Endovascular device sustains BP reductions
- Alcohol renal denervation safe for BP reduction